Lakshmi Subhadradevi
Overview
Explore the profile of Lakshmi Subhadradevi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
M S A, K C, Bhargavan R, Somanathan T, Subhadradevi L
J Mol Histol
. 2024 May;
55(3):227-240.
PMID: 38696048
Liposarcoma (LPS) is a rare malignancy of adipocytic differentiation. According to World Health Organization classification, LPS comprises of four principle subtypes Atypical lipomatous tumor/Well-differentiated liposarcoma (ATL/WDLPS), Dedifferentiated liposarcoma (WDLPS), Myxoid...
2.
Parambil S, Antony G, Littleflower A, Subhadradevi L
Biochimie
. 2024 Mar;
222:132-150.
PMID: 38494109
The incidence of breast cancer is perpetually growing globally, and it remains a major public health problem and the leading cause of mortality in women. Though the aberrant activities of...
3.
Littleflower A, Parambil S, Antony G, Subhadradevi L
Biochimie
. 2024 Jan;
220:107-121.
PMID: 38184121
Altered aerobic glycolysis is the robust mechanism to support cancer cell survival and proliferation beyond the maintenance of cellular energy metabolism. Several investigators portrayed the important role of deregulated glycolysis...
4.
Parambil S, Thankayyan S, Antony G, Littleflower A, Augustine P, Somanathan T, et al.
Med Oncol
. 2023 Apr;
40(5):137.
PMID: 37014473
Aside from the high prevalence of incidents of breast cancer, the high grade of heterogeneity and the dearth of standard treatment guidelines make triple-negative breast cancer (TNBC) the most refractory...
5.
Antony G, Littleflower A, Parambil S, Subhadradevi L
Med Oncol
. 2023 Feb;
40(4):108.
PMID: 36842157
Therapies targeting the PD-1/PD-L1 axis have recently been implemented for triple negative breast cancer (TNBC) management with limited efficacy, indicating that this axis may promote tumor growth by means other...
6.
Littleflower A, Antony G, Parambil S, Subhadradevi L
Appl Biochem Biotechnol
. 2023 Jan;
195(10):5838-5854.
PMID: 36708494
Breast cancer is the frequently diagnosed cancer and the leading cancer death among women. The growing tumour of the breast is composed of both normoxic and hypoxic cells, and the...
7.
Antony G, Augustine P, Parambil S, Littleflower A, Kattoor J, Krishna K, et al.
Clin Exp Med
. 2022 Jul;
23(3):859-869.
PMID: 35810258
Antitumor immune evasion is a hallmark for the development and progression of cancer. Tumor cells adopt various mechanisms to escape the host immune system recognition. One such mechanism is the...
8.
Majumder A, Dharan A, Baral I, Varghese P, Mukherjee A, Subhadradevi L, et al.
FASEB Bioadv
. 2020 Mar;
1(9):525-537.
PMID: 32123848
Abnormal proliferation and disrupted differentiation of hematopoietic progenitors mark leukemia. Histone cell cycle regulator A (HIRA), a histone chaperone, regulates hemogenic to hematopoietic transition involved in normal hematopoiesis. But, its...
9.
Elango K, Suresh A, Erode E, Subhadradevi L, Ravindran H, Iyer S, et al.
Asian Pac J Cancer Prev
. 2011 Jul;
12(4):889-96.
PMID: 21790221
Background: Human papilloma virus (HPV) is an important risk factor for head and neck cancer, specifically oropharyngeal cancer, but its association with oral tongue squamous cell carcinoma (SCC) is uncertain....